1. Home
  2. OSCR vs BIO Comparison

OSCR vs BIO Comparison

Compare OSCR & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Oscar Health Inc.

OSCR

Oscar Health Inc.

HOLD

Current Price

$29.93

Market Cap

10.0B

Sector

Finance

ML Signal

HOLD

Logo Bio-Rad Laboratories Inc.

BIO

Bio-Rad Laboratories Inc.

HOLD

Current Price

$381.95

Market Cap

10.1B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
OSCR
BIO
Founded
2012
1952
Country
United States
United States
Employees
N/A
N/A
Industry
Accident &Health Insurance
Biotechnology: Laboratory Analytical Instruments
Sector
Finance
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
10.0B
10.1B
IPO Year
2021
1994

Fundamental Metrics

Financial Performance
Metric
OSCR
BIO
Price
$29.93
$381.95
Analyst Decision
Hold
Buy
Analyst Count
8
4
Target Price
$16.88
★ $339.75
AVG Volume (30 Days)
★ 4.9M
243.5K
Earning Date
05-06-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 142.61
EPS
★ 3.16
N/A
Revenue
★ $11,701,427,000.00
$2,583,200,000.00
Revenue This Year
$63.89
$2.74
Revenue Next Year
$5.30
$3.20
P/E Ratio
$9.14
★ N/A
Revenue Growth
★ 27.50
0.65
52 Week Low
$10.69
$236.73
52 Week High
$34.48
$396.23

Technical Indicators

Market Signals
Indicator
OSCR
BIO
Relative Strength Index (RSI) 43.26 59.15
Support Level $28.13 $364.41
Resistance Level $33.08 $396.23
Average True Range (ATR) 1.93 9.28
MACD -0.40 -1.15
Stochastic Oscillator 24.35 71.71

Price Performance

Historical Comparison
OSCR
BIO

About OSCR Oscar Health Inc.

Oscar Health Inc is a healthcare technology company built around a full stack technology platform and a relentless focus on serving its members. It offers Individual & Family plans and health technology solutions that power the healthcare industry. Oscar operates as one segment to sell insurance to individuals, families and employees through the federal and state-run healthcare exchanges formed in conjunction with the Patient Protection and Affordable Care Act (ACA) and leverages its technology platform to provide services via its Oscar offering.

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

Share on Social Networks: